Abstract
Of 72 blood isolates of Enterobacter spp. collected over an 8-year period, 50% (36 of 72) were derepressed or partially derepressed AmpC mutants. The extended-spectrum β-lactamase (ESBL) production rate was 43% (31 of 72 isolates), and 67.3% (31 of 46) of extended-spectrum cephalosporin-resistant strains produced ESBLs. Thus, a confirmatory test for ESBL production is necessary for extended-spectrum cephalosporin-resistant Enterobacter spp.
Original language | English |
---|---|
Pages (from-to) | 3159-3161 |
Number of pages | 3 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 48 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2004 Aug |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases